cysteine and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

cysteine has been researched along with 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amaro, RE; Baronio, R; Chen, CK; Chung, BP; Demir, Ö; Hall, LV; Hatfield, GW; Kaiser, P; Lathrop, RH; Lin, DW; Luecke, H; Richard Chamberlin, A; Salehi, F; Wallentine, BD; Wassman, CD	1
Bykov, VJN; Wiman, KG; Zawacka-Pankau, J; Zhang, Q	1

Other Studies

2 other study(ies) available for cysteine and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

Article	Year
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53. Nature communications, 2013, Volume: 4 Topics: Apoptosis Regulatory Proteins; Aza Compounds; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Computational Biology; Cyclin-Dependent Kinase Inhibitor p21; Cysteine; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Dynamics Simulation; Mutant Proteins; Oxepins; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Proto-Oncogene Proteins; Reproducibility of Results; Structure-Activity Relationship; Transcription, Genetic; Tumor Suppressor Protein p53	2013
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277. Cell death & disease, 2018, 05-01, Volume: 9, Issue:5 Topics: Amino Acid Substitution; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cysteine; Humans; Mutation, Missense; Protein Domains; Protein Stability; Tumor Suppressor Protein p53	2018

Article

Year

Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53.

Nature communications, 2013, Volume: 4

Topics: Apoptosis Regulatory Proteins; Aza Compounds; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Computational Biology; Cyclin-Dependent Kinase Inhibitor p21; Cysteine; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Dynamics Simulation; Mutant Proteins; Oxepins; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Proto-Oncogene Proteins; Reproducibility of Results; Structure-Activity Relationship; Transcription, Genetic; Tumor Suppressor Protein p53

2013

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277.

Cell death & disease, 2018, 05-01, Volume: 9, Issue:5

Topics: Amino Acid Substitution; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cysteine; Humans; Mutation, Missense; Protein Domains; Protein Stability; Tumor Suppressor Protein p53

2018